Search Results - "Bullinger, Lars"

Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance

Sobas, Marta Anna, Turki, Amin T., Ramiro, Angela Villaverde, Hernandez-Sanchez, Alberto, Elicegui, Javier Martinez, Gonzalez, Teresa, Melchor, Raul Azibeiro, Abaigar, Maria, Tur, Laura, Dall'Olio, Daniele, Sträng, Eric, Tettero, Jesse M., Castellani, Gastone, Benner, Axel, Döhner, Konstanze, Thiede, Christian, Metzeler, Klaus H., Haferlach, Torsten, Damm, Frederik, Ayala, Rosa, Martinez-Lopez, Joaquin, Mills, Ken I., Sierra, Jorge, Lehmann, Sören, Della Porta, Matteo G., Mayer, Jiri, Reinhardt, Dirk, Medina, Ruben Villoria, Schulze-Rath, Renate, Barbus, Martje, Hernandez-Rivas, Jesus Maria, Huntly, Brian J. P., Ossenkoppele, Gert, Döhner, Hartmut, Bullinger, Lars

electronic

Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in Germany

Weidl, Daniel^{Aff1, IDs1106002505068z_cor1}, Capper, David, Onken, Julia, Liu, Ilon, Glaser, Doris, Orben, Felix, Eberle, Karolin, Coburger, Jan, Bullinger, Lars

ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker: CHRONIC LYMPHOCYTIC LEUKEMIA

Thorvaldsdottir, Birna^Aff1, Mansouri, Larry^Aff1, Sutton, Lesley-Ann, Nadeu, Ferran^{Aff2, Aff3}, Meggendorfer, Manja, Parker, Helen, Brieghel, Christian^{Aff6, Aff7}, Laidou, Stamatia, Moia, Riccardo, Rossi, Davide^{Aff10, Aff11}, Kotaskova, Jana^{Aff12, Aff13, Aff14}, Delgado, Julio, Rodríguez-Vicente, Ana E.^{Aff15, Aff16, Aff17}, Benito, Rocío^{Aff15, Aff16, Aff17}, Rigolin, Gian Matteo, Bonfiglio, Silvia, Scarfò, Lydia^{Aff19, Aff20}, Mattsson, Mattias, Davis, Zadie, Baliakas, Panagiotis, Rapado, Inmaculada^{Aff23, Aff24}, Miras, Fatima, Martinez-Lopez, Joaquín^{Aff23, Aff24}, de la Serna, Javier^{Aff23, Aff24}, Hernández Rivas, Jesús María^{Aff15, Aff16, Aff17}, Larráyoz, María José, Calasanz, María José, Smedby, Karin E., Espinet, Blanca, Puiggros, Anna, Bullinger, Lars, Bosch, Francesc, Tazón-Vega, Bárbara, Baran-Marszak, Fanny, Oscier, David, Nguyen-Khac, Florence, Zenz, Thorsten, Terol, Maria Jose, Cuneo, Antonio, Hernández-Sánchez, María^{Aff15, Aff16, Aff17, Aff34}, Pospisilova, Sarka^{Aff12, Aff13, Aff14}, Gaidano, Gianluca, Niemann, Carsten U.^{Aff6, Aff7, Aff35}, Campo, Elias^{Aff2, Aff3, Aff36, Aff37}, Strefford, Jonathan C., Ghia, Paolo^{Aff19, Aff20}, Stamatopoulos, Kostas^Aff8, Rosenquist, Richard^{Aff1, Aff38, IDs41375025026155_cor1}

A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents: ACUTE MYELOID LEUKEMIA

Shahswar, Rabia, Gabdoulline, Razif, Krueger, Katja, Wichmann, Martin, Götze, Katharina S.^{Aff2, Aff3}, Braitsch, Krischan, Meggendorfer, Manja, Schmalbrock, Laura, Bullinger, Lars, Modemann, Franziska, Fiedler, Walter, Krauter, Juergen, Kaun, Stephan, Rotermund, Susanne, Voß, Andreas, Behrens, Yvonne Lisa, Bergmann, Anke Katharina, Koller, Elisabeth, Beutel, Gernot, Thol, Felicitas, Heidel, Florian, Heuser, Michael^{Aff1, Aff12, IDs41375024025016_cor1}

Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype

Leppä, Aino-Maija^{Aff1, Aff2, Aff3}, Grimes, Karen^Aff4, Jeong, Hyobin^{Aff4, Aff5, Aff6}, Huang, Frank Y.^{Aff1, Aff2, Aff3}, Andrades, Alvaro, Waclawiczek, Alexander^{Aff1, Aff2}, Boch, Tobias, Jauch, Anna, Renders, Simon^{Aff1, Aff2, Aff9}, Stelmach, Patrick^{Aff1, Aff2, Aff9}, Müller-Tidow, Carsten, Karpova, Darja^{Aff1, Aff2}, Sohn, Markus^{Aff1, Aff2}, Grünschläger, Florian^{Aff1, Aff2, Aff3}, Hasenfeld, Patrick, Benito Garagorri, Eva, Thiel, Vera^{Aff1, Aff2, Aff3}, Dolnik, Anna, Rodriguez-Martin, Bernardo, Bullinger, Lars, Mrózek, Krzysztof^{Aff11, Aff12}, Eisfeld, Ann-Kathrin^{Aff11, Aff12}, Krämer, Alwin, Sanders, Ashley D.^{Aff14, Aff15, Aff16}, Korbel, Jan O.^{Aff4, Aff17, IDs4158802401999x_cor1}, Trumpp, Andreas^{Aff1, Aff2, Aff18, IDs4158802401999x_cor2}

Application of precision medicine in clinical routine in haematology—Challenges and opportunities

Wästerlid, Tove, Cavelier, Lucia, Haferlach, Claudia, Konopleva, Marina, Fröhling, Stefan, Östling, Päivi, Bullinger, Lars, Fioretos, Thoas, Smedby, Karin E.

Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Translational Genomic and Functional Studies of Leukemia, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Translationella genomiska och funktionella studier av leukemi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Originator

Acute myeloid leukemia: does sex matter?

Tettero, Jesse M.^{Aff1, Aff2, Aff3, IDs4137502402435z_cor1}, Cloos, Jacqueline^{Aff1, Aff2}, Bullinger, Lars

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

Hernández-Sánchez, Alberto^{Aff1, Aff2, Aff3}, González, Teresa^{Aff2, Aff3}, Sobas, Marta, Sträng, Eric, Castellani, Gastone, Abáigar, María^{Aff2, Aff3}, Valk, Peter J. M., Villaverde Ramiro, Ángela^{Aff2, Aff3}, Benner, Axel, Metzeler, Klaus H., Azibeiro, Raúl^{Aff1, Aff2}, Tettero, Jesse M., Martínez-López, Joaquín, Pratcorona, Marta, Martínez Elicegui, Javier^{Aff2, Aff3}, Mills, Ken I., Thiede, Christian, Sanz, Guillermo^{Aff15, Aff16}, Döhner, Konstanze, Heuser, Michael, Haferlach, Torsten, Turki, Amin T.^{Aff20, Aff21}, Reinhardt, Dirk, Schulze-Rath, Renate, Barbus, Martje, Hernández-Rivas, Jesús María^{Aff1, Aff2, Aff3, Aff25}, Huntly, Brian, Ossenkoppele, Gert, Döhner, Hartmut, Bullinger, Lars^{Aff27, IDs41375024023334_cor30}

The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities

Ramberger, Evelyn^{Aff1, Aff2, Aff3}, Sapozhnikova, Valeriia^{Aff1, Aff2, Aff3}, Ng, Yuen Lam Dora, Dolnik, Anna, Ziehm, Matthias^{Aff2, Aff4}, Popp, Oliver^{Aff2, Aff4}, Sträng, Eric, Kull, Miriam, Grünschläger, Florian^{Aff6, Aff7, Aff8}, Krüger, Josefine, Benary, Manuela, Müller, Sina, Gao, Xiang, Murgai, Arunima^{Aff1, Aff3}, Haji, Mohamed^{Aff2, Aff4}, Schmidt, Annika, Lutz, Raphael^{Aff6, Aff7, Aff9}, Nogai, Axel, Braune, Jan, Laue, Dominik, Langer, Christian, Khandanpour, Cyrus, Bassermann, Florian, Döhner, Hartmut, Engelhardt, Monika, Straka, Christian, Hundemer, Michael, Beule, Dieter, Haas, Simon^{Aff1, Aff2, Aff3, Aff4, Aff6, Aff7}, Keller, Ulrich^{Aff1, Aff2, Aff3}, Einsele, Hermann, Bullinger, Lars^{Aff1, Aff3}, Knop, Stefan^{Aff14, Aff15, Aff16, IDs43018024007843_cor33}, Mertins, Philipp^{Aff2, Aff4, IDs43018024007843_cor34}, Krönke, Jan^{Aff1, Aff3, IDs43018024007843_cor35}

A high proportion of germline variants in pediatric chronic myeloid leukemia

Krumbholz, Manuela^{Aff1, Aff2, Aff3}, Dolnik, Anna, Sträng, Eric, Ghete, Tabita^{Aff1, Aff3}, Skambraks, Sabrina, Hutter, Stephan, Simonis, Alfred, Stegelmann, Frank, Suttorp, Meinolf, Horn, Anselm H.C.^{Aff8, Aff9}, Sticht, Heinrich, Haferlach, Torsten, Bullinger, Lars^{Aff4, Aff10}, Metzler, Markus^{Aff1, Aff2, Aff3, IDs12943024021095_cor14}

Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy

Gross, Sophia, Ihlow, Jana^{Aff1, Aff2, Aff3, IDs41408024011405_cor2}, Busack, Leonie, Adamiak, Kacper, Schrezenmeier, Jens^{Aff1, Aff3}, Jesse, Julia, Schwarz, Michaela, Flörcken, Anne, Vuong, Lam Giang, Rieger, Kathrin, Krönke, Jan^{Aff1, Aff4}, le Coutre, Philipp^{Aff1, Aff5}, Boldt, Vivien, von Brünneck, Ann-Christin, Horst, David, Burmeister, Thomas^{Aff1, Aff5}, Blau, Igor-Wolfgang, Keller, Ulrich^{Aff1, Aff4}, Bullinger, Lars^{Aff1, Aff4, Aff5}, Westermann, Jörg^{Aff1, Aff5, IDs41408024011405_cor20}

Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients

Halik, Adriane, Tilgner, Marlon, Silva, Patricia, Estrada, Natalia, Altwasser, Robert, Jahn, Ekaterina, Heuser, Michael^{Aff3, Aff4}, Hou, Hsin-An, Pratcorona, Marta, Hills, Robert K., Metzeler, Klaus H., Fenwarth, Laurene, Dolnik, Anna, Terre, Christine, Kopp, Klara, Blau, Olga, Szyska, Martin, Christen, Friederike, Krönke, Jan^{Aff1, Aff16}, Vasseur, Loïc, Löwenberg, Bob, Esteve, Jordi, Valk, Peter J. M., Duchmann, Matthieu, Chou, Wen-Chien, Linch, David C., Döhner, Hartmut, Gale, Rosemary E., Döhner, Konstanze, Bullinger, Lars^{Aff1, Aff16}, Yoshida, Kenichi, Damm, Frederik^{Aff1, Aff16, IDs13045024015901_cor32}

Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Venditti, Adriano ^{1, 2, ∗}, Palmieri, Raffaele ¹, Maurillo, Luca ², Röllig, Christoph ³, Wierzbowska, Agnieszka ^{4, 5}, de Leeuw, David ⁶, Efficace, Fabio ⁷, Curti, Antonio ⁸, Ngai, Lok Lam ⁶, Tettero, Jesse ⁶, Adès, Lionel ⁹, Almeida, Antonio ¹⁰, Bullinger, Lars ¹¹, Dennis, Mike ¹², Esteve, Jordi ¹³, Ferrara, Felicetto ¹⁴, Heuser, Michael ¹⁵, Huls, Gerwin ¹⁶, Lübbert, Michael ¹⁷, Mehta, Priyanka ¹⁸, Montesinos, Pau ¹⁹, Pabst, Thomas ²⁰, Récher, Christian ²¹, Rossi, Giuseppe ²², Russell, Nigel ²³, Sierra, Jorge ²⁴, Stauder, Reinhard ^{25, 26}, Vey, Norbert ²⁷, Walter, Roland B. ²⁸, Wang, Eunice ²⁹, Nier, Samantha ³⁰, Martins, Carolina Garcez ³⁰, Ossenkoppele, Gert ⁶

Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Voso, Maria Teresa, Guarnera, Luca, Lehmann, Sören, Doehner, Konstanze, Doehner, Hartmut, Platzbecker, Uwe, Russell, Nigel, Dillon, Richard, Thomas, Ian, Ossenkoppele, Gert, Haferlach, Torsten, Vignetti, Marco, La Sala, Edoardo, Piciocchi, Alfonso, Fazi, Paola, Ramiro, Angela Villaverde, Gimenez, Lura Tur, Gurnari, Carmelo, Bullinger, Lars, Hernandez-Rivas, Jesus Maria

print

Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

Arends, Christopher Maximilian, Kopp, Klara, Hablesreiter, Raphael, Estrada, Natalia, Christen, Friederike, Moll, Ute Martha, Zeillinger, Robert, Schmitt, Wolfgang Daniel, Sehouli, Jalid^{Aff5, Aff6}, Kulbe, Hagen^{Aff5, Aff6}, Fleischmann, Maximilian, Ray-Coquard, Isabelle, Zeimet, Alain, Raspagliesi, Francesco, Zamagni, Claudio, Vergote, Ignace^{Aff12, Aff13}, Lorusso, Domenica, Concin, Nicole, Bullinger, Lars^{Aff1, Aff15}, Braicu, Elena Ioana^{Aff5, Aff6}, Damm, Frederik^{Aff1, Aff15, IDs41375024022533_cor21}

Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancer

Fröhlich, Ann-Kathrin^{Aff1, Aff2, Aff3, Aff4}, Porthun, Jan^{Aff1, Aff4, Aff5}, Talha, Khawaja M., Lena, Alessia^{Aff1, Aff2, Aff3, Aff7}, Hadzibegovic, Sara^{Aff1, Aff2, Aff3, Aff7}, Wilkenshoff, Ursula^{Aff1, Aff7, Aff8}, Sonntag, Frederike^{Aff1, Aff2, Aff3, Aff4}, Nikolski, Anja^{Aff1, Aff2, Aff3, Aff4}, Ramer, Luisa Valentina^{Aff1, Aff2, Aff3, Aff4}, Zeller, Tanja^{Aff9, Aff10, Aff11}, Keller, Ulrich^{Aff12, Aff13, Aff14}, Bullinger, Lars^{Aff13, Aff15}, Anker, Stefan D.^{Aff2, Aff3, Aff16}, Haverkamp, Wilhelm^{Aff2, Aff3, Aff16}, von Haehling, Stephan^{Aff17, Aff18}, Doehner, Wolfram^{Aff2, Aff3, Aff4, Aff19}, Rauch, Ursula^{Aff1, Aff2, Aff7}, Skurk, Carsten^{Aff1, Aff7}, Cleland, John G. F., Butler, Javed^{Aff6, Aff21}, Coats, Andrew J. S., Landmesser, Ulf^{Aff1, Aff2, Aff7, Aff8}, Karakas, Mahir^{Aff11, Aff23}, Anker, Markus S.^{Aff1, Aff2, Aff3, Aff7, IDs0039202402400x_cor24}

Reduced monocytic IL10 expression in PD1 inhibitor-treated patients is a harbinger of severe immune-related adverse events

Rosnev, Stanislav ^{a, b}, Sterner, Baldur ^{a, b}, Schiele, Phillip ^{a, b}, Kolling, Stefan ^{a, b, c}, Martin, Markus ^a, Flörcken, Anne ^{a, d}, Erber, Barbara ^e, Wittenbecher, Friedrich ^{a, f}, Kofla, Grzegorz ^a, Kurreck, Annika ^a, Lang, Tonio Johannes Lukas ^a, von Einem, Jobst C. ^a, de Santis, Maria ^{e, g}, Pelzer, Uwe ^a, Stintzing, Sebastian ^a, Bullinger, Lars ^{a, d}, Klinghammer, Konrad ^{a, h}, Geisel, Dominik ⁱ, Ochsenreither, Sebastian ^{a, d, h}, Frentsch, Marco ^{a, b, h, 1}, Na, Il-Kang ^{a, d, f, j, ⁎, 1}

Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders

Mougiakakos, Dimitrios ¹, Sengupta, Ranjita ^{2, ⁎}, Gold, Ralf ³, Schroers, Roland ⁴, Haghikia, Aiden ⁵, Lorente, Mario ², Pendleton, Michael ², Register, Ames ², Heesen, Christoph ⁶, Kröger, Nicolaus ⁷, Schett, Georg ⁸, Mackensen, Andreas ⁹, Podoll, Amber ¹⁰, Gutman, Jonathan ¹¹, Furie, Richard ¹², Bayer, Ruthee ¹³, Distler, Jörg H.W. ¹⁴, Dietrich, Sascha ¹⁵, Krönke, Gerhard ¹⁶, Bullinger, Lars ¹⁷, Walker, Karen ²

Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Mansouri, Larry, Thorvaldsdottir, Birna, Sutton, Lesley-Ann, Karakatsoulis, Georgios, Meggendorfer, Manja, Parker, Helen, Nadeu, Ferran, Brieghel, Christian, Laidou, Stamatia, Moia, Riccardo, Rossi, Davide, Catherwood, Mark, Kotaskova, Jana, Delgado, Julio, Rodriguez-Vicente, Ana E., Benito, Rocio, Rigolin, Gian Matteo, Bonfiglio, Silvia, Scarfo, Lydia, Mattsson, Mattias, Davis, Zadie, Gogia, Ajay, Rani, Lata, Baliakas, Panagiotis, 1977, Foroughi-Asl, Hassan, Jylha, Cecilia, Skaftason, Aron, Rapado, Inmaculada, Miras, Fatima, Martinez-Lopez, Joaquin, de la Serna, Javier, Rivas, Jesus Maria Hernandez, Thornton, Patrick, Larrayoz, Maria Jose, Calasanz, Maria Jose, Fesus, Viktoria, Matrai, Zoltan, Bodor, Csaba, Smedby, Karin E., Espinet, Blanca, Puiggros, Anna, Gupta, Ritu, Bullinger, Lars, Bosch, Francesc, Tazon-Vega, Barbara, Baran-Marszak, Fanny, Oscier, David, N'Guyen-Khac, Florence, Zenz, Thorsten, Terol, Maria Jose, Cuneo, Antonio, Hernandez-Sanchez, Maria, Pospisilova, Sarka, Mills, Ken, Gaidano, Gianluca, Niemann, Carsten U., Campo, Elias, Strefford, Jonathan C., Ghia, Paolo, Stamatopoulos, Kostas, Rosenquist, Richard

electronic

Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin

Rücker, Frank G. ¹, Bullinger, Lars ², Cocciardi, Sibylle ¹, Skambraks, Sabrina ¹, Luck, Tamara J. ^{1, 2}, Weber, Daniela ¹, Krzykalla, Julia ³, Pozek, Ema ³, Schneider, Isabelle ¹, Corbacioglu, Andrea ¹, Gaidzik, Verena I. ¹, Meid, Annika ¹, Aicher, Sophia ¹, Stegelmann, Frank ¹, Schrade, Anika ¹, Theis, Frauke ¹, Fiedler, Walter ⁴, Salih, Helmut R. ⁵, Wulf, Gerald ⁶, Salwender, Hans ⁷, Schroeder, Thomas ⁸, Götze, Katharina S. ⁹, Kühn, Michael W. M. ¹⁰, Lübbert, Michael ¹¹, Schlenk, Richard F. ^{12, 13}, Benner, Axel ³, Thol, Felicitas ¹⁴, Heuser, Michael ¹⁴, Ganser, Arnold ¹⁴, Döhner, Hartmut ¹, Döhner, Konstanze ^{1, ∗}